Genetec - A baby step

Genetec fixes private placement exercise at RM2.61 per share to raise RM178m

Genetec A baby step
Publish date: Tue, 31 Jan 2023, 04:23 PM
Investors, let's embark on a remarkable journey together.

Give GENETEC the time it deserves, and watch our Battery Day plans flourish!

Visit my blog for insights that will empower you to make informed decisions and maximize your investment. Discover the link between company potential and industry trends: [ https://klse1.i3investor.com/blogs/genetec_rm400/blidx.jsp].

Start small, dream big, and embrace the key to success with GENETEC.

 

https://www.theedgemarkets.com/node/653583

 

KUALA LUMPUR (Jan 31): Genetec Technology Bhd has fixed the issue price of its private placement exercise at RM2.61 per share to raise some RM177.99 million. 

The issue price represents a discount of approximately 2.69% to the volume weighted-average of the shares for the five market days up to and including Jan 30 of RM2.6821 per share. 

The private placement involves the issuance of 68.2 million placement shares to independent third-party investors. This represents 10% of the total number of issued shares of 681.96 million as at Dec 30, 2022, the industrial automation house said in a bourse filing on Tuesday (Jan 31). 

Genetec said earlier the funds will be mainly used for its business expansion plan, particularly on improving and upgrading its manufacturing facilities for automated industrial systems and equipment, and provision of value-added services for customers in the electric vehicle and energy storage industries, as well as working capital requirements. 

CIMB has been appointed as the principal adviser for the private placement. CIMB and CLSA Securities Malaysia Sdn Bhd are joint placement agents for the exercise. 

Genetec shares were flat at RM2.65 each at Tuesday’s noon break, valuing the ACE-Market listed group at RM1.81 billion. 

 

 

========================================

 

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
GENETEC TECHNOLOGY BERHAD ("GENETEC" OR THE "COMPANY")

PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN GENETEC ("SHARES") TO INDEPENDENT THIRD-PARTY INVESTORS TO BE IDENTIFIED AT A LATER DATE, REPRESENTING UP TO 10.0% OF THE COMPANYS ENLARGED TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) ("PRIVATE PLACEMENT")

We refer to the Company’s announcements dated 12 January 2023, 13 January 2023, 30 January 2023 and 31 January 2023 respectively in relation to the Private Placement. Unless otherwise stated, the terms used herein shall have the same meaning as defined in the said announcements.

 

On behalf of the Board, CIMB wishes to announce that the book-building exercise in relation to the Private Placement has been completed.

 

The Company will be issuing 68,196,180 Placement Shares, representing 10% of the total number of issued shares of Genetec.

 

The Company has fixed the issue price of RM2.61 per Placement Share (“Issue Price”). The Issue Price represents a discount of approximately 2.69% to the 5-day VWAP of Genetec Shares up to and including 30 January 2023, being the last market day immediately preceding the price-fixing date, of RM2.6821 per Genetec Share. The total gross proceeds to be raised from the Private Placement is RM177.99 million.

 

This announcement is dated 31 January 2023.

 

==============================================

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
GENETEC TECHNOLOGY BERHAD ("GENETEC" OR THE "COMPANY")

PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN GENETEC ("SHARES") TO INDEPENDENT THIRD-PARTY INVESTORS TO BE IDENTIFIED AT A LATER DATE, REPRESENTING UP TO 10.0% OF THE COMPANY'S ENLARGED TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) ("PROPOSED PRIVATE PLACEMENT")

We refer to the Company’s announcements dated 12 January 2023, 13 January 2023 and 30 January 2023 respectively in relation to the Proposed Private Placement. Unless otherwise stated, the terms used herein shall have the same meaning as defined in the said announcements.

 

On behalf of the Board, CIMB wishes to announce that Bursa Securities had, vide its letter dated 31 January 2023, approved the listing and quotation of up to 71,669,520 Placement Shares to be issued on the ACE Market of Bursa Securities, subject to the following conditions:

 

1. Genetec and CIMB must fully comply with the relevant provisions under the ACE Market Listing Requirements pertaining to the implementation of the Proposed Private Placement;

 

2. Genetec and CIMB to inform Bursa Securities upon the completion of the Proposed Private Placement; and

 

3. Genetec to furnish Bursa Securities with a written confirmation of its compliance with the terms and conditions of Bursa Securities’ approval once the Proposed Private Placement is completed.

 

This announcement is dated 31 January 2023.

 

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment